Our aim was to determine the total blood loss associated with surgery for fracture of the hip and to identify risk factors for increased blood loss. We prospectively studied 546 patients with hip fracture. The total blood loss was calculated on the basis of the haemoglobin difference, the number of transfusions and the estimated blood volume. The hidden blood loss, in excess of that observed during surgery, varied from 547 ml (screws/ pins) to 1473 ml (intramedullary hip nail and screw) and was significantly associated with medical complications and increased hospital stay. The type of surgery, treatment with aspirin, intra-operative hypotension and gastro-intestinal bleeding or ulceration were all independent predictors of blood loss.
Our aim was to determine the total blood loss associated with surgery for fracture of the hip and to identify risk factors for increased blood loss. We prospectively studied 546 patients with hip fracture. The total blood loss was calculated on the basis of the haemoglobin difference, the number of transfusions and the estimated blood volume. The hidden blood loss, in excess of that observed during surgery, varied from 547 ml (screws/ pins) to 1473 ml (intramedullary hip nail and screw) and was significantly associated with medical complications and increased hospital stay. The type of surgery, treatment with aspirin, intra-operative hypotension and gastro-intestinal bleeding or ulceration were all independent predictors of blood loss.
We conclude that total blood loss after surgery for hip fracture is much greater than that observed intra-operatively. Frequent post-operative measurements of haemoglobin are necessary to avoid anaemia.
The actual total blood loss during elective hip and knee replacement surgery has been found to be considerably larger than that observed during surgery and collected in drains postoperatively. 1, 2 This hidden blood loss has not been evaluated in patients with fracture of the hip. They are usually frail and elderly and are particularly vulnerable to anaemia and hypovolaemia. [3] [4] [5] Previous studies have reported only the observed amount of intra-operative bleeding and the blood collected in drains. 6, 7 Arthroplasty and the use of calcium antagonists have been reported as risk factors for increased blood loss. [6] [7] [8] Our aim was first to evaluate the total blood loss for the individual surgical procedures and, secondly, to identify associations and independent risk factors for peri-operative blood loss after surgery for fracture of the hip.
Patients and Methods
Between September 2002 and July 2004, 600 consecutive patients with fracture of the hip were studied prospectively. Our study was part of Hvidovre University Hospital Hip Fracture Project, which had ethical approval and was approved by the Danish data protection agency.
The patients were treated in a dedicated hip fracture unit within the department regardless of their pre-operative status. All those admitted had primary surgical intervention for their fracture. During the entire period, a multimodel rehabilitation programme was in effect. 9, 10 This included surgery within 24 hours and the immediate initiation of epidural anaesthesia and analgesia and low-dose morphine on admission, continued for 96 hours post-operatively whenever possible. 11 Between admission and the fourth post-operative day the patients received supplementary oxygen at the rate of 2 l/min whenever they were supine. All patients received cefuroxime (1.5 g) immediately preoperatively and low-molecular-weight heparin (enoxaparin, 40 mg subcutaneously once daily) from the time of admission. They were mobilised on the day of operation and received an intensive physiotherapy programme of two daily 30-minute sessions starting on the first post-operative day. They were rehabilitated primarily in the orthopaedic ward until they fulfilled the discharge criteria or, if this was deemed to be unobtainable, until transfer was arranged to a nursing home.
Standardised fluid and transfusion procedures were enforced. Fluid therapy consisted of rehydration fluid (Na 40 mmol/l, K 20 mmol/l, glucose 250 mmol/l) 20 ml/kg on admission, intra-operative infusion of isotonic saline (5 ml/kg/hour) supplemented by 6% hydroxyethyl starch 130/0.4 on signs of hypovolaemia. Hypotension was treated with ephedrine, 10 mg intravenously and 40 mg intramuscularly. Blood loss was replaced with 6% hydroxyethyl starch 130/0.4, at a rate of 1:1 until the level of haemoglobin fell below 100 g/l, at which point transfusion of red blood cells was initiated. In the post-anaesthesia care unit all patients received glucose (500 ml intravenously; 278 mmol/l). Post-operatively a regular diet was supplemented with three protein drinks each day. Postoperative fluid therapy was standardised and intravenous fluids were only administered if the patients' oral intake was less than 1500 ml daily, or if they were hypovolaemic, when 500 ml of 6% hydroxyethyl starch 130/0.4 was given.
The level of haemoglobin was measured on admission, in the post-anaesthetic care unit one hour after the end of anaesthesia and every morning until the fifth post-operative day. Measurement was by venous sampling with Hemocue (Hemocue, Vedbaek, Denmark) and analysing by the methaemoglobin method (Advia; Bayer, Lyngby, Denmark). The patients were transfused with blood if the level of haemoglobin fell below 100 g/1 at any point during their admission. The final haemoglobin value was defined as the last sample obtained on either the third or fourth post-operative day. In the case of patients who were discharged on the second post-operative day (n = 79), this value was used for the final haemoglobin.
We used national guidelines for the surgical techniques for the various types of fracture. Undisplaced intracapsular fractures were treated by parallel implants (Olmed screws, Olmed Medical AB, Sweden, or two Hansson pins, LJ Medical, Denmark). In displaced intracapsular fractures the treatment depended on age. If the patient was younger than 75 years of age the fracture was reduced and internally fixed by parallel screws or Hansson pins and if older than 75 years of age, an uncemented hemiarthroplasty (Austin Moore stem combined with an Ultima bipolar head, Johnson & Johnson, United Kingdom) was used. If the latter was not stable peri-operatively, a cemented hemiarthroplasty was used. All trochanteric and basocervical fractures were treated with a dynamic hip screw (Hiploc DHS, Biomet Inc., Warsaw, Indiana), whereas transtrochanteric, subtrochanteric and trochanteric fractures with a subtrochanteric component received an intramedullary hip nail and screw (Smith & Nephew Inc., Memphis, Tennessee). Wound drains were not used. Collection of data. This was done prospectively. The preoperative functional level was determined using the New Mobility Score, 12 medical conditions, the American Society of Anesthesiologists (ASA) classification, 13 the type of anaesthesia, the lowest intra-operative mean arterial pressure and the type of surgery. Complications, length of stay and 30-day mortality were also recorded. Weight and height were assessed upon admission. Since the patients could not be weighed on a conventional scale, their weight was estimated by the orthopaedic surgeon supported by the patients' own information.
14 For 71 patients, height was not assessed pre-operatively and was instead calculated using a gender-and age-dependent mean height-to-weight relationship.
The regular use of aspirin in any dose before the fracture, the regular use of non-steroidal anti-inflammatory drugs (NSAIDs), treatment with vitamin K antagonists or any regular medication with calcium antagonists were all recorded. All patients admitted before January 2004 (n = 408) were given rofecoxib from the time of admission and registered as receiving cyclo-oxygenase-2 inhibitors. After this date, cyclo-oxygenase-2 therapy was not used in the immediate peri-operative period and only patients who had been receiving it before their fracture were given it postoperatively.
Medical complications were defined as the presence of any of the following: cerebrovascular accident, delirium, acute myocardial infarction or unstable angina, acute congestive heart failure, new-onset arrhythmia, pneumonia, respiratory insufficiency, gastric or duodenal ulceration, renal dysfunction (defined as a level of creatinine greater than 200 mmol/1), septicaemia, pulmonary embolus or a deep-vein thrombosis. Deep wound infections and failure of surgical fixation were analysed separately, as were gastro-intestinal ulcerations confirmed by endoscopy, or clinical signs of gastro-intestinal bleeding (haematemesis or melaena). Blood loss. Intra-operative blood loss was evaluated by the measured suction loss plus the weight of loss in swabs. The total blood loss was calculated based on the haemoglobin level and the estimated blood volume. The latter was determined according to gender, body mass and height. 15 The formulae used were as follows:
Blood volume(l) = height (m) 3 The calculated loss of haemoglobin in the peri-operative period was based on the assumptions that the blood volume would be the same on admission and on the third postoperative day, and that all the red blood cell transfusions contained the same number of cells. The formulae used was as follows: where Hgb loss is the calculated total haemoglobin loss (g), Hgb adm is the haemoglobin value on admission, Hgb fin is the final recorded haemoglobin value on day three or four and Hgb trans is the total amount of haemoglobin (g) in the transfused red blood cells before the measurement of Hgb fin . The calculated blood loss was estimated using the following formula:
Blood loss in ml = (Hgb loss /Hgb adm ) x 1000 2 .
In order to assess the potential impact of dehydration on admission on the entire model and the results, the total peri-operative blood loss was also calculated from the level of haemoglobin on admission, corrected by a factor of 0.9, in order to simulate 10% dehydration in all patients. Statistical analysis. The tests for significant differences between normally distributed data samples were performed using Student's t -test for independent samples. The test for difference in blood loss between different surgical procedures was done with the Kruskal-Wallis test. All perioperative data were analysed for univariate influence on total blood loss. Multivariate linear regression analysis was performed to identify independent factors associated with total blood loss and only factors assumed to be potentially causative were entered in the model. The type of surgical procedure was entered in the analysis, coded as a dummy variable, with the dynamic hip screw procedure chosen as a control since this was the most frequent and was closest to the mean in terms of blood loss. The level of significance was set at p < 0.05. All data analyses were performed using SPSS version 10.1 software (SPSS Inc., Chicago, Illinois).
Results
Of the 600 consecutive patients, four were excluded because their fractures were pathological, two because the primary surgery had been a resection of the femoral head and 48 because of poor collection of data. This left 546 patients for the final analysis. The patients excluded because of insufficient data did not differ in their peri-operative characteristics from those who were included. Table I gives the details of the patients included in the study.
One patient with a basocervical fracture received an arthroplasty instead of a dynamic hip screw. Ten patients with trochanteric fractures received an intramedullary hip nail and screw due to a subtrochanteric component of their fracture, and nine patients with intracapsular fractures received a dynamic hip screw instead of parallel implants at the discretion of the operating surgeon. The peri-operative haemoglobin and transfusion data are presented in Table  II . Intra-operative transfusions were given in 70 patients. The median haemoglobin value in the post-anaesthesia care unit was 100 g/l which was exactly the transfusion threshold. Consequently, 216 patients received red blood cell transfusions post-operatively on the day of surgery. Nevertheless, the median haemoglobin value on the first and second post-operative days was only 103 g/l, despite the fact that 179 patients received transfusions on the first and 137 on the second post-operative days. The final haemoglobin value was below the transfusion threshold in 137 patients.
The observed and calculated values for blood loss are shown in Table III . The median blood loss was significantly (p < 0.001) different between the four categories of surgical procedure and in all types of procedure the calculated blood loss was in excess of that observed intra-operatively. The calculated blood loss based on the haemoglobin values corrected for 10% dehydration are also presented, and vary from 226 ml to 1618 ml of total peri-operative loss. There was no difference between the total blood loss of displaced versus undisplaced intracapsular fractures treated by parallel implants.
Pre-fracture cardiovascular disease and medication with aspirin were both associated with increased calculated blood loss (Table IV) . Post-operative cardiovascular medical complications, evidence of gastro-intestinal bleeding or ulceration and renal dysfunction were associated with calculated blood loss, as was post-operative length of stay, but not mortality. All factors which could potentially be causatively related to blood loss were included in the multivariate analysis model. The results of the linear regression are presented in Table V . Factors independently associated with increased total blood loss were the pre-operative use of aspirin, intraoperative mean arterial pressure of less than 60 mmHg and peri-operative evidence of gastro-intestinal bleeding. The regression coefficient and 95% confidence interval (CI) for each independent variable are presented and, since all independent variables are bivariate, the regression coefficient can be interpreted as the impact of the considered variable on bleeding.
Discussion
Hidden blood loss in connection with surgery for hip fracture was substantial, with an excess of up to six times that observed during the surgical procedure. Both hidden and total blood loss was procedure-specific with the greatest losses occurring with the use of a dynamic hip screw and intramedullary hip nail and screw. The loss of blood was associated with medical complications and increased length of hospitalisation, but not with surgical complications. Our study is the first to evaluate the total blood loss in surgery for hip fracture. Hidden blood loss has been evaluated in elective knee and hip replacement by similar methods to ours, and has been found to be 100% and 30% of the observed loss, respectively. 1, 2 The hidden blood loss may be caused by many factors. First, the trauma per se leads to a pre-operative blood loss, especially in extracapsular fractures, which may not be reflected in the level of haemoglobin on admission. Secondly, insufficient haemostasis may contribute to continued haemorrhage post-operatively. Thirdly, medication with an anticoagulant effect may increase pre-, intra-and post-operative bleeding and, finally, other sources of bleeding, for example, from the gastro-intestinal tract, may add to the overall blood loss.
The validity of the calculated blood loss depends upon the accuracy of the admission haemoglobin, the final haemoglobin values used and the estimated blood volume. A similar method has been used in other elective orthopaedic procedures.
1,2 The trauma of a hip fracture clearly leads to blood loss, but this will not necessarily result in a decrease in haemoglobin for the first hours. The primary factor leading to an overestimation of the patient's total haemoglobin mass on admission is pre-fracture dehydration. In our analysis we made calculations to establish the impact of dehydration of 10% in all patients on admission (a mean deficit of 6 l). The results showed a potential exaggeration of the blood loss in intracapsular fractures, whereas that in the other procedures was from 800 ml to 1400 ml in excess of the loss observed intra-operatively. A multivariate analysis on the corrected values for total blood loss showed similar levels of significance for the individual risk factors as in the original model.
Fluid retention after surgery can be in the order of several litres, which could lead to an underestimation of the final haemoglobin concentration and, thus, an exaggeration of total blood loss. 16 The mean intra-operative intravenous fluid administered was 1066 ml (100 to 4000). To minimise the effect of fluid retention the final haemoglobin was measured on the third or fourth post-operative day, when fluid retention may be less prominent than in the earlier postoperative period. However, any fluid retention leads to a larger blood volume than that used in the calculations, which would give an underestimation of post-operative blood loss. On balance, the calculation methods used seem to be acceptable and to provide a reasonable estimate of total blood loss with a possible bias towards an overestimation in procedures with parallel implants.
Anaemia has been associated with increased mortality in patients refusing transfusion, 17, 18 but transfusion therapy has been associated with an increased risk of infection in trauma patients and those having surgery for malignancy. 19, 20 Descriptive studies have found some association between post-operative anaemia and poor functional outcome and delirium in patients with hip fracture, 21, 22 but this has not yet been confirmed by larger randomised studies. 23 Although restrictive transfusion guidelines are generally recommended, it is also acknowledged that patients with cardiovascular disease probably benefit from a more liberal transfusion therapy. At our institution about 65% of patients with hip fractures have some degree of cardiovascular disease. In our study a liberal transfusion trigger of 100 g/l was used to standardise transfusion therapy and to minimise the potential effects of anaemia on the post-operative outcome.
The univariate analysis found an association between increased blood loss and medical complications. This suggested a deleterious effect of peri-operative anaemia, allowing for the fact that patients will be anaemic for some time until diagnosed and corrected, despite the aggressive transfusion threshold enforced in this regimen. We found no association between blood loss and mortality, despite the very high blood loss in some patients. This could potentially be attributed to the liberal transfusion policy enforced. Although it is tempting to make an association between a large post-operative blood loss with concurrent haematoma and surgical complications such as failure of fixation and infections, we found none.
Previous studies have advocated increased vigilance in the post-operative period in order to reduce the adverse effect of sustained anaemia. 24 In our study, in which levels of haemoglobin were controlled both post-operatively on the day of surgery and again each day thereafter, 216 patients were below the transfusion threshold immediately post-operatively. Although all of these received transfusions there still was a need for a mean of 0.51 units of blood (0 to 4; 1 unit = 55 g of haemoglobin or 300 ml) per patient on the first post-operative day and 0.38 units (0 to 3) on the second day.
Administration of aspirin and NSAIDs inhibits platelet function, but has not been linked to increased blood loss or transfusion requirements in surgery for hip fracture. 25 We found aspirin to be independently and significantly associated with an increased blood loss. NSAIDs, which otherwise have been linked with increased peri-operative bleeding, 26 were not associated with increased blood loss by the few patients receiving them. This may be explained by cessation of the NSAID therapy upon admission and replacement by cyclo-oxygenase-2 inhibitors, which have no effect on platelet function. 27, 28 Calcium antagonists have previously been associated with increased blood loss in surgery for fracture of the hip, 8 but we found no association. The impact of anticoagulative therapy with lowmolecular-weight heparin on total blood loss cannot be commented on since it was standard treatment in all patients. However, with the documented large blood loss it may be important to evaluate different anticoagulant regimes on total blood loss in this high-risk group of patients.
Regional anaesthesia has been associated with decreased blood loss, 29 but the implications for our results are minimal because of the almost universal application of regional anaesthesia. A factor which was significantly and independently associated with increased blood loss was a measured intra-operative mean arterial pressure below 60 mmHg, which is in contrast to the reduced blood loss which is expected with hypotensive anaesthesia in hip replacement surgery. 30 A possible explanation could be that the excessive pre-and intra-operative blood loss may have caused more profound hypotension intra-operatively. Alternatively, it may be that profound hypotension decreased the quality of surgical haemostasis resulting in increased postoperative blood loss. Gastro-intestinal haemorrhage or ulceration was included in the multivariate analysis despite the fact that its association with total blood loss could be both causative and dependent. Previous studies of morbidity in hip fracture have rarely described gastro-intestinal complications and most studies of thromboprophylaxis 31 usually only report major bleeding complications. Gastrointestinal bleeding was reported to be as low as 2% in a large study of selected patients with hip fracture. 32 We chose to assess all patients with any clinical signs of gastrointestinal haemorrhage or ulceration and found an incidence of 8% and a mean 'contribution' (B coefficient) to blood loss of 263 ml, which calls for further studies on prophylactic measures for gastro-intestinal complications in this group of patients.
Measures which can reduce both intra-and post-operative blood loss need to be investigated further in this highrisk group especially in those with trochanteric and subtrochanteric fractures. Intra-operative tranexamic acid has been shown to decrease observed blood loss both in hip and knee replacement. 2, 33, 34 Unfortunately, it has not yet been evaluated in surgery for fracture of the hip. Such studies should be conducted in future.
In conclusion, total blood loss after surgery for hip fracture is up to six times that observed during the surgical procedure. In order to avoid prolonged post-operative anaemia, frequent measurements of the levels of haemoglobin are recommended. The surgical procedure, the preoperative use of aspirin, low intra-operative blood pressure and peri-operative gastro-intestinal bleeding or ulceration are independently associated with increased blood loss.
